Proactive Investors
08 Jun 2026, 06:39 UTC · 7h ago
IXICO expands scientific network in Alzheimer's and Parkinson's disease
Proactive Investors
08 Jun 2026, 06:39 UTC · 7h ago
Story key points
4 claims · impact-rated
IXICO has signed a new agreement with an additional brine water supply partner to increase production at its IOsorb iodine extraction facility. — Increased raw material supply directly enables higher production capacity and potential revenue growth for the company's iodine business.
+0.60IXICO has entered a research collaboration with the Paris Brain Institute to evaluate neuromelanin-sensitive MRI approaches as biomarkers for Parkinson’s research. — Expanding clinical research capabilities and validating AI-driven analysis tools increases the company's value proposition to biopharma clients.
+0.40IXICO has added three senior specialists—Professors Jeffrey Cummings, Charles DeCarli, and Stéphane Lehéricy—to its advisory board. — Adding key opinion leaders provides scientific validation and improves the company's credibility within the neuroimaging sector.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
IXICO representatives have been invited to join The Michael J. Fox Foundation’s MRI Advisory Committee to standardize quantitative MRI biomarkers. — Participation in industry-standard setting bodies positions the company as a leader in the development of Parkinson's research protocols.
+0.20Ticker attribution
Model heads
The company expanded its scientific advisory board, launched new Parkinson's research collaborations, and secured a new brine water supply partner to increase production.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
GlobeNewsWire
2h ago
